Association of Psoriasis With the Risk for Type 2 Diabetes Mellitus and Obesity

TY - JOUR

T1 - Association of Psoriasis With the Risk for Type 2 Diabetes Mellitus and Obesity

AU - Lønnberg, Ann Sophie

AU - Skov, Lone

AU - Skytthe, Axel

AU - Kyvik, Kirsten Ohm

AU - Pedersen, Ole Birger

AU - Thomsen, Simon Francis

PY - 2016/7/1

Y1 - 2016/7/1

N2 - IMPORTANCE Psoriasis has been shown to be associated with overweight and type 2 diabetes mellitus. The genetic association is unclear. OBJECTIVE To examine the association among psoriasis, type 2 diabetes mellitus, and body mass index (BMI) (calculated as weight in kilograms divided by height in meters squared) in twins. DESIGN, SETTING, AND PARTICIPANTS This cross-sectional, population-based twin study included 34 781 Danish twins, 20 to 71 years of age. Data from a questionnaire on psoriasis was validated against hospital discharge diagnoses of psoriasis and compared with hospital discharge diagnoses of type 2 diabetes mellitus and self-reported BMI. Data were collected in the spring of 2002. Data were analyzed from January 1 to October 31, 2014. MAIN OUTCOMES AND MEASURES Crude and adjusted odds ratios (ORs)were calculated for psoriasis in relation to type 2 diabetes mellitus, increasing BMI, and obesity in the whole population of twins and in 449 psoriasis-discordant twins. Variance component analysis was used to measure genetic and nongenetic effects on the associations. RESULTS Among the 34 781 questionnaire respondents, 33 588 with complete data were included in the study (15 443 men [46.0%]; 18 145 women [54.0%]; mean [SD] age, 44.5 [7.6] years). After multivariable adjustment, a significant association was found between psoriasis and type 2 diabetes mellitus (odds ratio [OR], 1.53; 95%CI, 1.03-2.27; P = .04) and between psoriasis and increasing BMI (OR, 1.81; 95%CI, 1.28-2.55; P = .001 in individuals with a BMI>35.0). Among psoriasis-discordant twin pairs, the association between psoriasis and obesity was diluted in monozygotic twins (OR, 1.43; 95%CI, 0.50-4.07; P = .50) relative to dizygotic twins (OR, 2.13; 95%CI, 1.03-4.39; P = .04). Variance decomposition showed that additive genetic factors accounted for 68%(95%CI, 60%-75%) of the variance in the susceptibility to psoriasis, for 73%(95%CI, 58%-83%) of the variance in susceptibility to type 2 diabetes mellitus, and for 74%(95%CI, 72%-76%) of the variance in BMI. The genetic correlation between psoriasis and type 2 diabetes mellitus was 0.13 (-0.06 to 0.31; P = .17); between psoriasis and BMI, 0.12 (0.08 to 0.19; P < .001). The environmental correlation between psoriasis and type 2 diabetes mellitus was 0.10 (-0.71 to 0.17; P = .63); between psoriasis and BMI, -0.05 (-0.14 to 0.04; P = .44). CONCLUSIONS AND RELEVANCE This study determines the contribution of genetic and environmental factors to the interaction between obesity, type 2 diabetes mellitus, and psoriasis. Psoriasis, type 2 diabetes mellitus, and obesity are also strongly associated in adults after taking key confounding factors, such as sex, age, and smoking, into account. Results indicate a common genetic etiology for psoriasis and obesity.

AB - IMPORTANCE Psoriasis has been shown to be associated with overweight and type 2 diabetes mellitus. The genetic association is unclear. OBJECTIVE To examine the association among psoriasis, type 2 diabetes mellitus, and body mass index (BMI) (calculated as weight in kilograms divided by height in meters squared) in twins. DESIGN, SETTING, AND PARTICIPANTS This cross-sectional, population-based twin study included 34 781 Danish twins, 20 to 71 years of age. Data from a questionnaire on psoriasis was validated against hospital discharge diagnoses of psoriasis and compared with hospital discharge diagnoses of type 2 diabetes mellitus and self-reported BMI. Data were collected in the spring of 2002. Data were analyzed from January 1 to October 31, 2014. MAIN OUTCOMES AND MEASURES Crude and adjusted odds ratios (ORs)were calculated for psoriasis in relation to type 2 diabetes mellitus, increasing BMI, and obesity in the whole population of twins and in 449 psoriasis-discordant twins. Variance component analysis was used to measure genetic and nongenetic effects on the associations. RESULTS Among the 34 781 questionnaire respondents, 33 588 with complete data were included in the study (15 443 men [46.0%]; 18 145 women [54.0%]; mean [SD] age, 44.5 [7.6] years). After multivariable adjustment, a significant association was found between psoriasis and type 2 diabetes mellitus (odds ratio [OR], 1.53; 95%CI, 1.03-2.27; P = .04) and between psoriasis and increasing BMI (OR, 1.81; 95%CI, 1.28-2.55; P = .001 in individuals with a BMI>35.0). Among psoriasis-discordant twin pairs, the association between psoriasis and obesity was diluted in monozygotic twins (OR, 1.43; 95%CI, 0.50-4.07; P = .50) relative to dizygotic twins (OR, 2.13; 95%CI, 1.03-4.39; P = .04). Variance decomposition showed that additive genetic factors accounted for 68%(95%CI, 60%-75%) of the variance in the susceptibility to psoriasis, for 73%(95%CI, 58%-83%) of the variance in susceptibility to type 2 diabetes mellitus, and for 74%(95%CI, 72%-76%) of the variance in BMI. The genetic correlation between psoriasis and type 2 diabetes mellitus was 0.13 (-0.06 to 0.31; P = .17); between psoriasis and BMI, 0.12 (0.08 to 0.19; P < .001). The environmental correlation between psoriasis and type 2 diabetes mellitus was 0.10 (-0.71 to 0.17; P = .63); between psoriasis and BMI, -0.05 (-0.14 to 0.04; P = .44). CONCLUSIONS AND RELEVANCE This study determines the contribution of genetic and environmental factors to the interaction between obesity, type 2 diabetes mellitus, and psoriasis. Psoriasis, type 2 diabetes mellitus, and obesity are also strongly associated in adults after taking key confounding factors, such as sex, age, and smoking, into account. Results indicate a common genetic etiology for psoriasis and obesity.

U2 - 10.1001/jamadermatol.2015.6262

DO - 10.1001/jamadermatol.2015.6262

M3 - Journal article

C2 - 27120802

SN - 2168-6068

VL - 152

SP - 761

EP - 677

JO - JAMA Dermatology

JF - JAMA Dermatology

IS - 7

ER -